Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

DOI: 10.1530/eje.0.1330735
European Journal of Endocrinology, Vol 133, Issue 6, 735-740
Copyright © 1995 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolf, E.
Right arrow Articles by Brem, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wolf, E.
Right arrow Articles by Brem, G.

Effects of growth hormone overproduction on grip strength of transgenic mice

Eckhard Wolf, Rüdiger Wanke, Emanuel Schenck, Walter Hermanns and Gottfried Brem

Wolf E, Wanke R, Schenck E, Hermanns W, Brem G. Effects of growth hormone overproduction on grip strength of transgenic mice. Eur J Endocrinol 1995;133:735–40. ISSN 0804–4643

Growth hormone (GH) is used by athletes like bodybuilders to increase muscle strength and weight gain. On the other hand, chronic hypersecretion of GH in active acromegaly may result in outwardly hypertrophied but functionally weaker muscles. As a model for studying long-term effects of GH on muscle strength, we analysed transgenic mice (TM) carrying rat phosphoenolpyruvate carboxykinasebovine GH (PEPCKbGH) fusion genes, which are expressed in liver and kidney but not in skeletal muscle. Circulating GH levels in TM ranged between 0.5 and 3 µg/ml, resulting in increased (p <0.001) body weight (wt) as well as increased (p <0.01) weights of forelimb and hindlimb muscles. However, muscle weight/body wt ratios of TM were 16–20% smaller than in controls (p<0.05), Forelimb grip strength of hemizygous TM (16 males, 132 ± 45 days old, body wt = 56.8 ± 8.3 g; 32 females, 146 ± 38 days old, body wt = 54.9 ± 6.1 g) and non-transgenic controls (28 males, 127 ± days old, body wt = 40.5±2.9 g; 33 females, 126 ±47 days old, body wt = 32.1 ± 3.6 g) was determined using an automated grip strength meter. Data were computed by analysis of variance, taking into account effects of group, sex and age. Least-squares means estimated for the grip strength (N) of male TM (1.91) and controls (1.92) were significantly (p<0.05) greater than those of female TM (1.78) and controls (1.61). A significant difference between groups was only seen in females (p <0.01). Least-squares means estimated for grip strength/body wt ratios (N/10 g) of male (0.34) and female TM (0.33) were 29% and 35% lower than those of male (0.48) and female controls (0.51), respectively (p <0.001). In summary, long-term elevated GH levels in TM increased muscle weight less efficiently than body weight, and muscle strength did not increase proportionally with muscle weight.

Eckhard Wolf, Lehrstuhl für Molekulare Tierzucht und Haustiergenetik, Ludwig-Maximilians-Universität München, Würmtalstraβe 221, 81375 München, Germany




This article has been cited by other articles:


Home page
 Endocr. Rev.Home page
L. J. Woodhouse, A. Mukherjee, S. M. Shalet, and S. Ezzat
The Influence of Growth Hormone Status on Physical Impairments, Functional Limitations, and Health-Related Quality of Life in Adults
Endocr. Rev., May 1, 2006; 27(3): 287 - 317.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
B. Olsson, M. Bohlooly-Y, O. Brusehed, O. G. P. Isaksson, B. Ahren, S.-O. Olofsson, J. Oscarsson, and J. Tornell
Bovine growth hormone-transgenic mice have major alterations in hepatic expression of metabolic genes
Am J Physiol Endocrinol Metab, September 1, 2003; 285(3): E504 - E511.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Sports. Med.Home page
M J Rennie
Claims for the anabolic effects of growth hormone: a case of the Emperor's new clothes?
Br. J. Sports Med., April 1, 2003; 37(2): 100 - 105.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
F. Frick, M. Bohlooly-Y, D. Linden, B. Olsson, J. Tornell, S. Eden, and J. Oscarsson
Long-term growth hormone excess induces marked alterations in lipoprotein metabolism in mice
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1230 - E1239.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Hoeflich, S. Nedbal, W. F. Blum, M. Erhard, H. Lahm, G. Brem, H. J. Kolb, R. Wanke, and E. Wolf
Growth Inhibition in Giant Growth Hormone Transgenic Mice by Overexpression of Insulin-Like Growth Factor-Binding Protein-2
Endocrinology, May 1, 2001; 142(5): 1889 - 1898.
[Abstract] [Full Text]

Home page
 Hum Mol GenetHome page
K. Tagawa, C. Taya, Y. Hayashi, M. Nakagawa, Y. Ono, R. Fukuda, H. Karasuyama, N. Toyama-Sorimachi, Y. Katsui, S. Hata, et al.
Myopathy phenotype of transgenic mice expressing active site-mutated inactive p94 skeletal muscle-specific calpain, the gene product responsible for limb girdle muscular dystrophy type 2A
Hum. Mol. Genet., May 22, 2000; 9(9): 1393 - 1402.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G.-X. Zhang, B.-G. Xiao, X.-F. Bai, P. H. van der Meide, A. Orn, and H. Link
Mice with IFN-{gamma} Receptor Deficiency Are Less Susceptible to Experimental Autoimmune Myasthenia Gravis
J. Immunol., April 1, 1999; 162(7): 3775 - 3781.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 European Society of Endocrinology.